Effects of mild asymptomatic primary hyperparathyroidism on bone mass in women with and without estrogen replacement therapy

2009 ◽  
Vol 9 (4) ◽  
pp. 509-514 ◽  
Author(s):  
Michael T. McDermott ◽  
Jan J. Perloff ◽  
Gerald S. Kidd
Keyword(s):  
Primary Hyperparathyroidism ◽  
Bone Mass ◽  
Replacement Therapy ◽  
Estrogen Replacement Therapy ◽  
Estrogen Replacement ◽  
Asymptomatic Primary Hyperparathyroidism

scholarly journals Efficacy of estrogen replacement therapy (ERT) on uterine growth and acquisition of bone mass in patients with Turner syndrome

2015 ◽  
Vol 62 (11) ◽  
pp. 965-970 ◽  
Author(s):  
Tomomi Nakamura ◽  
Taku Tsuburai ◽  
Aya Tokinaga ◽  
Izumi Nakajima ◽  
Reiko Kitayama ◽  
...  
Keyword(s):  
Bone Mass ◽  
Replacement Therapy ◽  
Turner Syndrome ◽  
Estrogen Replacement Therapy ◽  
Estrogen Replacement ◽  
Uterine Growth

scholarly journals Eldecalcitol increases bone mass in patients with Turner syndrome who have insufficient bone mass acquisition after estrogen replacement therapy

2018 ◽  
Vol 65 (6) ◽  
pp. 629-638 ◽  
Author(s):  
Taku Tsuburai ◽  
Tomomi Nakamura ◽  
Hiromi Yoshikata ◽  
Etsuko Miyagi ◽  
Hideya Sakakibara
Keyword(s):  
Bone Mass ◽  
Replacement Therapy ◽  
Turner Syndrome ◽  
Estrogen Replacement Therapy ◽  
Estrogen Replacement

The Effects of Transdermal Estradiol and Oral Conjugated Estrogens on Haemostasis Variables

1994 ◽  
Vol 71 (04) ◽  
pp. 420-423 ◽  
Author(s):  
Ulla-Beth Kroon ◽  
G Silfverstolpe ◽  
L Tengborn
Keyword(s):  
Replacement Therapy ◽  
Estrogen Replacement Therapy ◽  
Hormone Replacement ◽  
Plasminogen Activator Inhibitor ◽  
Estrogen Replacement ◽  
Transdermal Administration ◽  
Conjugated Estrogens ◽  
Transdermal Estradiol ◽  
Estrogen Administration ◽  
Activator Inhibitor

SummaryThe effects of oral and transdermal administration of estrogen replacement therapy (ERT) have been fairly well investigated regarding lipoprotein and carbohydrate metabolism, while the effects of different modes of estrogen administration on the haemostatic system have been less well studied.To delineate and compare the effects of perorally administered conjugated estrogens (CE) and transdermally administered estradiol (E2) in doses needed for hormone replacement therapy (HRT) on haemostasis parameters, 23 postmenopausal women were engaged in a study with an open cross-over design. The doses compared (0.625 mg CE and 50 μg E2/24h) are the lowest which, with few exceptions, eliminate climacteric symptoms. Both CE and E2 increased factor VII:C, factor VII:Ag, and the prothrombin fragment1+2. The increase in factor VII:Ag, however, was significantly higher after treatment with CE. These changes were all towards a state of hypercoagulability. Furthermore, CE decreased plasminogen activator inhibitor (PAI) and the thrombin-antithrombin complexes (TAT), as well as antithrombin (ATIII).

Effects of Estrogen Replacement Therapy on the Renin-Angiotensin System in Postmenopausal Women

Circulation ◽  
1997 ◽  
Vol 95 (1) ◽  
pp. 39-45 ◽  
Author(s):  
Heribert Schunkert ◽  
A.H. Jan Danser ◽  
Hans-Werner Hense ◽  
Frans H.M. Derkx ◽  
Susanne Ku¨rzinger ◽  
...  
Keyword(s):  
Replacement Therapy ◽  
Postmenopausal Women ◽  
Estrogen Replacement Therapy ◽  
Renin Angiotensin System ◽  
Estrogen Replacement ◽  
Angiotensin System ◽  
Renin Angiotensin
Sign in / Sign up

Export Citation Format

Share Document